NCCN 2012 Congress Webinar Series: Lung Cancers™: Adjuvant Therapy of Non-Small Cell Lung Cancer

May 31, 2012

This educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.


Earn 1.0 continuing education credits per webinar!

Target Audience

This webinar series is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with lung cancer.

Learning Objectives

Following this webinar, attendees should be able to:

  • Describe the role of adjuvant therapy in NSCLC
  • Select the most appropriate therapy for patients with NSCLC based on specific criteria (e.g., histology)
Additional information

This activity is supported by an educational donation provided by Amgen. This program is supported by education grants from Astellas, Celgene Corporation, Genentech, Lilly USA, LLC, and Pfizer.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
Course expires: 
Event starts: 
05/31/2012 - 1:00pm EDT
Event ends: 
05/31/2012 - 2:00pm EDT

Gregory A. Otterson, MD

The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician


Please login or register to take this course.